UiPath Announces Fiscal Second Quarter 2022 Financial Results Conference Call
- S&P, Nasdaq enjoy boost from big tech firms, Dow ends a hair lower
- Zillow (ZG) Stock Falls on Report Company Paused Home Purchases due to High Demand, a Temporary Halt Yields a Chance for Competitors Says Analyst
- Oil prices pull back as U.S. factory data intensifies demand concerns
- Chip Shortages are Increasingly Becoming a New Bearish Risk, Inflation Bearish for Consumer Electronics - TFI's Kuo
- Walt Disney (DIS) Stock Slips as Barclays Downgrades Amid Disney+ Growth Slowdown
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
NEW YORK--(BUSINESS WIRE)-- UiPath, Inc. (NYSE: PATH), a leading enterprise automation software company, today announced it will report financial results for its fiscal second quarter 2022 ended July 31, 2021 after the market close on Tuesday, September 7, 2021. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET.
UiPath Fiscal Second Quarter 2022 Financial Results Conference Call
When: Tuesday, September 7, 2021
Time: 5:00 pm ET
Conference ID: 13721284
Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll)
Replay: 1-877-660-6853 (US Toll-Free), 201-612-7415 (Toll)
(The replay will be available approximately two hours after the completion of the live call until 11:59 pm ET on September 21, 2021)
UiPath has a vision to deliver the Fully Automated Enterprise™, one where companies use automation to unlock their greatest potential. UiPath offers an end-to-end platform for automation, combining the leading Robotic Process Automation (RPA) solution with a full suite of capabilities that enable every organization to rapidly scale digital business operations.
Source: UiPath, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis
- AKVA group ASA: Israel Corp. announces results of its offer to purchase shares in AKVA group ASA
- AXA Partners Signs With Upptec to Automate the Claims Process
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!